CNTB
Connect Biopharma Holdings Ltd
0.8979$
-3.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 95.9% | 96.1% | 96.2% | 96.2% | 96.1% | 95.7% | 94.7% | 94.0% | 92.9% | 90.8% | 91.6% | 88.8% | |
| 56.6% | 84.2% | 83.0% | 83.0% | 91.4% | 77.2% | 51.5% | 49.1% | 56.2% | 68.4% | 76.6% | 62.1% | |
| 91.3% | 94.3% | – | 92.9% | 91.4% | 92.5% | – | 86.8% | – | 79.1% | – | 72.4% | |
| 2.2% | – | 0.0% | 0.3% | 3.2% | 1.0% | 0.0% | 0.2% | 0.0% | 0.3% | 0.0% | 6.8% | |
| 17.5% | – | – | -11.0% | -0.2% | – | – | – | – | – | – | – | |
| 186.2% | – | – | – | – | – | – | – | – | – | – | – | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | – | 0.1% | – | 0.1% | – | 0.1% | |
| 10.7% | 19.7% | 20.3% | 20.3% | 8.4% | 9.0% | 10.6% | 13.8% | 17.8% | 25.1% | 29.0% | 38.2% | |
| 10.4% | 19.3% | 19.9% | 19.9% | 8.0% | 8.4% | 9.2% | 13.0% | 17.0% | 24.3% | 28.4% | 37.5% | |
| 0.2% | 0.2% | – | 0.2% | 0.2% | 0.2% | – | 0.4% | – | 0.6% | – | 0.9% | |
| 8.0% | 6.1% | 1.7% | 1.7% | 4.7% | 0.3% | 0.9% | 2.8% | 3.0% | 3.5% | 7.2% | 4.6% | |
| 89.3% | 80.3% | 79.7% | 79.7% | 91.6% | 91.0% | 89.4% | 86.2% | 82.2% | 74.9% | 71.0% | 61.8% | |
| -325.3% | -428.4% | -258.9% | -258.9% | -441.0% | -341.0% | -383.7% | -445.5% | -572.6% | -714.8% | -699.6% | -1,006.4% | |
| 277.9% | 43.8% | 43.3% | 43.2% | 46.1% | 54.5% | 59.7% | 67.1% | 82.8% | 99.3% | 104.4% | 144.7% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.